Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK.

ABSTRACT:

Background

Acute Coronavirus Disease 2019 (COVID-19) has been associated with new-onset cardiovascular disease (CVD) and diabetes mellitus (DM), but it is not known whether COVID-19 has long-term impacts on cardiometabolic outcomes. This study aimed to determine whether the incidence of new DM and CVDs are increased over 12 months after COVID-19 compared with matched controls.

Methods and findings

We conducted a cohort study from 2020 to 2021 analysing electronic records for 1,356 United Kingdom family practices with a population of 13.4 million. Participants were 428,650 COVID-19 patients without DM or CVD who were individually matched with 428,650 control patients on age, sex, and family practice and followed up to January 2022. Outcomes were incidence of DM and CVD. A dif

SUBMITTER: Rezel-Potts E 

PROVIDER: S-EPMC9295991 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature